Skip to contentApplication 220934
- Type
- NDA
- Sponsor
- ELI LILLY AND CO
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | FOUNDAYO | ORFORGLIPRON CALCIUM | TABLET;ORAL | EQ 0.8MG BASE | Yes | No |
| 002 | FOUNDAYO | ORFORGLIPRON CALCIUM | TABLET;ORAL | EQ 2.5MG BASE | Yes | No |
| 003 | FOUNDAYO | ORFORGLIPRON CALCIUM | TABLET;ORAL | EQ 5.5MG BASE | Yes | No |
| 004 | FOUNDAYO | ORFORGLIPRON CALCIUM | TABLET;ORAL | EQ 9MG BASE | Yes | No |
| 005 | FOUNDAYO | ORFORGLIPRON CALCIUM | TABLET;ORAL | EQ 14.5MG BASE | Yes | No |
| 006 | FOUNDAYO | ORFORGLIPRON CALCIUM | TABLET;ORAL | EQ 17.2MG BASE | Yes | Yes |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 85914 | ORIG | 2026-05-15 |
| 85636 | ORIG | 2026-04-02 |
| 85635 | ORIG | 2026-04-02 |
| 85664 | ORIG | 2026-04-01 |